A detailed history of Bank Of America Corp transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Bank Of America Corp holds 26,935 shares of HBIO stock, worth $57,640. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,935
Previous 25,865 4.14%
Holding current value
$57,640
Previous $73,000 1.37%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.64 - $3.54 $2,824 - $3,787
1,070 Added 4.14%
26,935 $72,000
Q2 2024

Aug 14, 2024

BUY
$2.77 - $4.63 $42,763 - $71,477
15,438 Added 148.06%
25,865 $73,000
Q1 2024

May 15, 2024

SELL
$4.02 - $5.39 $99,909 - $133,957
-24,853 Reduced 70.45%
10,427 $44,000
Q4 2023

Feb 14, 2024

BUY
$4.0 - $5.49 $105,448 - $144,727
26,362 Added 295.6%
35,280 $188,000
Q2 2023

Aug 14, 2023

SELL
$4.19 - $6.16 $113,988 - $167,582
-27,205 Reduced 75.31%
8,918 $48,000
Q1 2023

May 12, 2023

BUY
$2.45 - $4.22 $66,757 - $114,986
27,248 Added 307.02%
36,123 $151,000
Q4 2022

Feb 10, 2023

BUY
$2.12 - $2.86 $725 - $978
342 Added 4.01%
8,875 $24,000
Q3 2022

Nov 14, 2022

BUY
$2.33 - $3.92 $17,472 - $29,396
7,499 Added 725.24%
8,533 $22,000
Q2 2022

Aug 12, 2022

SELL
$3.28 - $6.42 $81,084 - $158,708
-24,721 Reduced 95.99%
1,034 $0
Q1 2022

May 16, 2022

BUY
$5.16 - $7.14 $41,156 - $56,948
7,976 Added 44.86%
25,755 $160,000
Q4 2021

Feb 08, 2022

BUY
$6.37 - $8.18 $66,961 - $85,988
10,512 Added 144.65%
17,779 $125,000
Q3 2021

Nov 15, 2021

BUY
$6.98 - $8.47 $1,333 - $1,617
191 Added 2.7%
7,267 $51,000
Q2 2021

Sep 13, 2021

BUY
$5.44 - $8.4 $38,493 - $59,438
7,076 New
7,076 $59,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.